Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

1.64USD
20 Apr 2018
Change (% chg)

$-0.05 (-2.96%)
Prev Close
$1.69
Open
$1.68
Day's High
$1.70
Day's Low
$1.64
Volume
62,431
Avg. Vol
216,773
52-wk High
$9.55
52-wk Low
$1.51

Latest Key Developments (Source: Significant Developments)

Aratana Therapeutics Granted Conditional License For A Canine Osteosarcoma Therapeutic
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Advaxis Inc ::ARATANA THERAPEUTICS GRANTED CONDITIONAL LICENSE FOR A CANINE OSTEOSARCOMA THERAPEUTIC.ARATANA THERAPEUTICS-U.S. DEPARTMENT OF AGRICULTURE CENTER FOR VETERINARY BIOLOGICS GRANTED CONDITIONAL LICENSE​ FOR CANINE OSTEOSARCOMA VACCINE,AT-014.  Full Article

Amgen reports 8.9 pct passive stake in Advaxis as of Aug 1
Tuesday, 2 Aug 2016 

Amgen Inc Reports 8.9 Pct Passive Stake In Advaxis Inc As Of August 1 :Sec filing.  Full Article

Advaxis files for common stock offering
Tuesday, 2 Aug 2016 

Advaxis Inc :Files for common stock offering of up to 3.05 million shares - SEC filing.  Full Article

BRIEF-Advaxis Reports Q1 Loss Per Share $0.49

* ADVAXIS REPORTS FISCAL 2018 FIRST QUARTER FINANCIAL RESULTS AND ANNOUNCES CLINICAL HOLD IN AXALIMOGENE FILOLISBAC PHASE 1/2 COMBINATION STUDY WITH ASTRAZENECA’S IMFINZI® (DURVALUMAB)